Delivery Order SPE2DB20D1100-SPE2DB24FA1S9
Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The $1,577.28 award has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $78,864.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes valued at $142,793.60. The contract was awarded under firm fixed-price terms with an ultimate completion date of August 27, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's role as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the provision of the HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical product. The $3,943.20 Firm Fixed Price Delivery Order contract has a completion date of May 23, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract is a Delivery Order issued by the Defense Logistics Agency (DLA), a defense agency, with a Ceiling Value of $1,971.60 and a completion date of June 6, 2024. This is a Firm Fixed Price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The Firm Fixed Price Delivery Order, valued at $1,182.96, has a period of performance through June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,577.28 Delivery Order is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 16, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a completion date of March 1, 2024 and a potential value of $2,365.92. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite...
- This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $108,006.30 firm-fixed-price contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a hepatitis B vaccine. The order has an ultimate completion date of August 6, 2024. Amerisourcebergen is a key supplier of pharmaceutical and medical products to various federal agencies and healthcare programs,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $7,886.40 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, to be delivered by February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of $999,999,999.00 through December 31, 2025, which serves as...